Compatibility study of topical 0.25% hypericin (HyBryteTM) application in subjects with mycosis fungoides: Results of the HPN‐CTCL‐02 study - Alexander‐Savino, Carolina V.; Rumage, Adam; Pullion, Christopher; Straube, Richard; Schaber, Christopher J.; Gilmore, Elaine S.; Poligone, Brian (JEADV clinical practice, 2024)
Keywords: CTCL; cutaneous T‐cell lymphoma; electrocardiogram changes; pharmacokinetic; photodynamic therapy; QT prolongation; topical hypericin